Hong Kong stock market anomaly | Cristal Technology (02228.HK) rises by more than 5%, helping Zhiqing Biotechnology's new drug to receive clinical trial approval. The company's AI pharmaceutical business is steadily advancing commercialization.
According to the Securities Times app, ShinePine Technology (02228.HK) rose more than 5%, with an increase of 5.06% to 10.37 Hong Kong dollars as of the time of publication, with a trading volume of 9.64 billion Hong Kong dollars.
Latest
4 m ago
